|
PCYOX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
4.99870000947311E-09 |
| Normal-vs-Stage3 |
1.61270000020863E-07 |
| Normal-vs-Stage4 |
5.59099999999368E-05 |
| Stage1-vs-Stage2 |
8.195800E-01 |
| Stage1-vs-Stage3 |
7.424000E-02 |
| Stage1-vs-Stage4 |
5.863800E-01 |
| Stage2-vs-Stage3 |
2.075400E-01 |
| Stage2-vs-Stage4 |
7.065000E-01 |
| Stage3-vs-Stage4 |
5.831000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18119966532981E-11 |
| Normal-vs-AfricanAmerican |
8.54130000060849E-09 |
| Normal-vs-Asian |
2.715800E-03 |
| Caucasian-vs-AfricanAmerican |
2.832000E-01 |
| Caucasian-vs-Asian |
2.978600E-01 |
| AfricanAmerican-vs-Asian |
7.737800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.8873574338445E-12 |
| Normal-vs-Female |
6.34690000000937E-07 |
| Male-vs-Female |
1.024240E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.0908999975866E-08 |
| Normal-vs-Extreme_Weight |
2.71127564843709E-12 |
| Normal-vs-Obese |
9.23805476560347E-12 |
| Normal-vs-Extreme_Obese |
4.83240000004326E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.296420E-01 |
| Normal_Weight-vs-Obese |
6.313400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.629200E-01 |
| Extreme_Weight-vs-Obese |
1.501530E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.677000E-01 |
| Obese-vs-Extreme_Obese |
6.690400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.45150000000027E-06 |
| Normal-vs-Age(41-60Yrs) |
1.738609256563E-13 |
| Normal-vs-Age(61-80Yrs) |
5.68933788969161E-12 |
| Normal-vs-Age(81-100Yrs) |
9.11919999957433E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.808600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.298240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.183800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.928400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.121200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.413200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.82340817392424E-12 |
| Normal-VS-Type2 PRCC |
1.17670000410186E-08 |
| Normal-VS-KIRP CIMP |
1.070170E-02 |
| Normal-VS-Unclassified PRCC |
4.63849999521315E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.983850E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.273570E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.554460E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.077800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.045200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.500230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.82947015711943E-14 |
| Normal-vs-N1 |
1.79529999999595E-06 |
| Normal-vs-N2 |
1.769980E-02 |
| N0-vs-N1 |
2.936000E-02 |
| N0-vs-N2 |
2.829400E-01 |
| N1-vs-N2 |
9.905600E-01 |
|
|
